Cancer Network: Survival Advantage Demonstrated With Higher-Dose Rhenium-186 Nanoliposome in Recurrent Glioma Shared By: contributorSeptember 12, 2022 Andrew Brenner, MD, PhD, Medicine/Mays Cancer Center, is quoted in this article. Read More Share This Article!
